ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023

Rhea-AI Summary

ResMed (NYSE: RMD) announced its plans to release third-quarter financial results for fiscal year 2023 on April 27, after market close. The company will host a webcast at 1:30 p.m. PDT to discuss the results and share additional forward-looking information. The event demonstrates ResMed's commitment to transparency with investors and stakeholders. Following the live webcast, a replay will be available on the company’s website, providing convenient access to the information shared. ResMed, known for its innovative digital health technologies and cloud-connected medical devices, serves over 140 countries, aiming to enhance healthcare delivery for chronic conditions.

Positive

• Scheduled financial results release indicates transparency with investors.
• The company continues to lead in digital health technologies and medical devices.

Negative

• None.

SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on Thursday, April 27, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Earnings webcast details:

•	Location:	http://investor.resmed.com
•	Date:	Thursday, April 27, 2023
•	Time:	1:30 p.m. PDT / 4:30 p.m. EDT
•	International:	London, Thursday, April 27, 2023, 9:30 p.m. BST
		Sydney, Friday, April 28, 2023, 6:30 a.m. AEST

Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.

A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from April 27, 2023, until May 11, 2023, at:

•	U.S.: +1 877.660.6853
•	International: +1 201.612.7415
•	Conference ID: 13737758

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investors	For media
Amy Wakeham	Jayme Rubenstein
+1 858.836.5000	+1 858.836.6798
investorrelations@resmed.com	news@resmed.com

FAQ

When will ResMed release its Q3 fiscal 2023 results?

ResMed will release its Q3 fiscal 2023 results on April 27, 2023.

What time is the ResMed earnings webcast scheduled?

The earnings webcast is scheduled for 1:30 p.m. PDT on April 27, 2023.

Where can I listen to ResMed's earnings call?

You can listen to ResMed's earnings call via the webcast link on their investor relations website.

Will there be a replay of ResMed's earnings webcast?

Yes, a replay of the earnings webcast will be available on ResMed’s website approximately two hours after the live event.

What is ResMed's focus in healthcare?

ResMed focuses on innovative solutions for chronic diseases, primarily through digital health technologies and cloud-connected devices.